Lorillard
Evaluation of the Role of Carbon Monoxide and Nicotine in the Pathogenesis of Arteriosclerosis and Cardiovascular Disease
Fields
- Author
- Schievelbein, H.
- Type
- PSCI, SCIENTIFIC PUBLICATION
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH/MAPS
- FOOT, FOOTNOTE
- BIBL, BIBLIOGRAPHY
- Area
- LIBRARY/SUBJECT BOXES
- Site
- G39
- Request
- R1-080
- Named Organization
- Ahf, American Health Foundation
- Comm on Medical + Biological Effects O
- Federal Health Office
- Subcomm on Carbon Monoxide of 770000
- Comm on Medical + Biological Effects O
- Named Person
- Anderson
- Armitage
- Aronow
- Astrup
- Ayres
- Davies
- Dawber
- Dinman
- Doll
- Doyle
- Fisher
- Forbes
- Gijka
- Goldsmith
- Grosgogeat
- Grundke
- Helovaara
- Hernberg
- Hill
- Issac
- Jones
- Kannel
- Kjeldsen
- Kuller
- Langone
- Rand
- Robinson
- Schievelbein, H.
- Scott
- Sinclair
- Surgeon General
- Topper
- Turner
- Vanvunakis
- Armitage
- Date Loaded
- 20 Dec 2001
- Master ID
- 81211048/1331
Related Documents:- 81211093-1100 the American Health Foundation Newsletter Vol. 5 / No. 1
- 81211101-1108 the American Health Foundation Newsletter Vol. 4 / No. 2
- 81211109-1116 the American Health Foundation Newsletter Vol. 4 / No. 1
- 81211117-1128 the American Health Foundation Newsletter Vol.3 / No. 3
- 81211153
- 81211154-1156 Forum: Workshop on Carbon Monoxide and Cardiovascular Disease
- 81211157-1163 Risk Factors on Arteriosclerosis and Cardiovascular Disease with Special Emphasis on Cigarette Smoking
- 81211164-1171 Effect of Carbon Monoxide on Cardiovascular Disease
- 81211172-1182 The Epidemiology of Carbon Monoxide in Cardiovascular Disease in Industrial Environments A Review
- 81211183-1188 Compliance with the Carbon Monoxide Standard in the Workplace
- 81211189-1196 Model Studies Linking Carbon Monoxide and / or Nicotine to Arteriosclerosis and Cardiovascular Disease
- 81211197-1203 Carbon Monoxide, Tobacco Smoking, and the Pathogenesis of Atherosclerosis
- 81211204-1216 Mechanisms of Carbon Monoxide Toxicity
- 81211217-1226 The Prevalence of Carboxyhemoglobinemia in New Yorkers and Its Effects on the Coronary and Systemic Circulation
- 81211227-1237 Animal Models and Acute and Long - Term Carbon Monoxide Intoxication
- 81211238-1244 Formation and Analysis of Carbon Monoxide in Cigarette Mainstream and Sidestream Smoke
- 81211245-1251 Thiocyanate As An Indicator of Tobacco Smoking
- 81211252-1262 Reduction of Carbon Monoxide in Cigarette Smoke
- 81211263-1272 Methods to Reduce Carbon Monoxide Levels at the Workplace
- 81211284-1297 Potential Mechanisms for the Augmentation of Atherosclerosis and Atherosclerotic Disease by Cigarette Smoking
- 81211301
- 81211302-1319 Bibliography
- 81211321-1329 Untitled Document 81211321/1329
- Litigation
- Feda/Produced
- Author (Organization)
- Academic Press
- German Heart Center
- Preventive Medicine
- German Heart Center
- Characteristic
- DRFT, DRAFT
- UCSF Legacy ID
- upm54c00
Document Images
_ - ;
!EZ~~ __. _ H. SCHIEVELBEIN
Ihas been often suggested that heavy smoking is merely a symptom of a particular
type of personality or neurosis, anxiety, or psychosocial stress and that it is the
linked association that is being measured in the epidemiological studies. Argu-
ments of this kind are hard to substantiate and even more difficult to refute.
Perhaps it is best to consider whether there is any reasonable mechanism evident
whereby cigarette smoking could be casually responsible for the enormous load of
excess mortality that is being attributed to it.
~ DEVELOPMENT OF CVD
The mechanism by which a coronary artery can become completely closed is
quite well understood. In general, the sequence of events is that the vessels
become progressively narrowed by the developing arteriosclerosis and then.a -
more sudden even( occurs that has the effect of blocking completely the residual
lumen. Very often, angina pectoris, due to an oxygen deficiency of the myocar-
dium, precedes such an event. The processes that may contribute to the infarction
and sudden death include thrombosis, embolism, plaque rupture, and intimal
hemorrhages. There is the question as to what extent cigarette smoke may be the
direct cause of such an acute event. In the investigations, described as follows, it
was presumed that the cause of CVD in general can be attributed to a disturbed fat
metabolism. Recent investigations, which apparently show a correlation between
CVD and a decreased serum level of high-density lipoproteins (HDL) due to .
smoking, seem to substantiate the presumption (21. 23):-
Whether cigarette smoke increases the permeability of the arterial endothelium
as stated by Doyle (19) in this symposium, whether it influences the thrombus
formation by aggregation of the thrombocytes. or whether some other mechanism
plays a role are open questions. Tobacco smoke exposure in animals has never
produced an arteriosclerotiZ condition similar to the human desease. In spite of
this, two components of tobacco smoke assumed to be of major importance have
been studied intensively. Below, I will discuss the acute and chronic effects of CO
and nicotine on the development of CVD from the beginning to the possible
catastrophic event of heart infarction or sudden death.
This meeting has brought to light the importance of the necessity to review the
available data, inasmuch as very recent Hndings could not be considered by all
participants, i.e., the contribution of Astrup and Kjeldsen (8).
CHRONIC EFFECTS OF NICOTINE
~
A presupposition for a possible chronic effect of nicotine in humans is a mea-
surable concentration in the blood of smokers. This condition has been estab-
lished by several authors, as can be seen in Table I. Nicotine has a special affinity
forcertain_or_gans, i._e., the brain and the adrenals, as has been seen in animals and,
therefore, it can be assumed that this distribution holds true for humans too.
' With regard to this fact, several studies have dealt with the possible effects of
nicotine administration on the development of arterial wall injuries in animals,
especially in rabbits which are predisposed to develop arteriosclerosis spontane- .
ously. The main results are that nicotine, when administered alone, has no injuring
effect on the intima. It is remarkable, however, that the daily dose of nicotine used
in these animal studies, in general, was several times higher per kilogram body _
i
i
1~.~ ~------ ' --- ----- -----------'.
-
opyrf96r
I

WORKSHOP: CARBON MO`OxJUE AND CVD
TABLE I
BLO00 LEVELS OF NICVTINE IV C(OARET?E SNOKERS
Aulhors Nicotine content
Ing/mll
Remarks
MUhod
Schievelbein and 25 Whofe venous blood. Gas-liquid
Gru_ndke. 1968 - mean of 6 smokers chromalogcrphy
Isaac and Rand. 1972 25 Plasma of venous
blood.
mean of 5 smokers Gas-liquid
chromalography
Langone. Gjika. and e73 btanimal value in Radioimmunoasiay
van Vunakis, 1973 - scraof about
240 smukers
Armitage ct a1L. 1974 30-40 Arterial whole bloud. hteasuremenr or
Hill, 1975
4 smokers
39 Sera.
mean of 6 smokers
-'C-labeled niculine
Radioimmunoassav
weight than the daily amount of nicotine absorbed by heavy smokers. This is
summarized in Table 2. By assuming that I mg of nicotine is absorbed into humans
for every cigarette smoked, up to L?00 cigarettes have to be smoked and inhaled
per day by an individual to absorb amounts of nicotine similar to those adminis-
tered to the animals in the above-mentioned experiments where no arterial wall-
injuring effects of nicotine were observed. When nicotine was administered-to
hypercholeslerolemic animals. no, or only very-limited, additive effects of
nicotine on the arterial wall injuries Were observed. Therefore, since very large
doses of nicotine are unable to produce arteriosclerosis in rabbits, it is very
unlikely that nicotine is lhe agent in tobacco smoke responsible for the increased
incidence of arteriosclerosis in smokers. This may be valid in spite of the fact that
nicotine exerts some influence on carbohvdrate-and fat metabolism.
CHRONIC EFFECTS OF CARBON MONOXIDE -
Several investigations have studied the possible relation between ambient CO
or COHb levels and CVD.
Kuller and co-workers (35) found no evidence for a correlation betnceen
myocardial infarction or sudden death with ambient CO levels. Postmortem.
TABLE 2
AMDIINTS or NICOTIYE USED IN EYPERIME?rAL SrCOIrs P' RA9BIrs'
_
Authors
Nicotine
(per kg'day9 Corresponding no. of
- eigatenes -
- pcr day -
Alherogenic
effect
Fisher et af.. 1973 0.3 ng 35 - None
Schievelbein et al., 1970 2.3 ng - 160 None
Grosgogeat rr al-. 1965 10 mg 700 None
Scott et aL. 1973 6-18 ng 41A1-1:00 None
Compilation by Astrup (1976).
p

H. SCHIEVELBEIN . . ; _
ACUTE EFFECTS OF NICOTINE
Nicotine acts by release of catecholamines, as is summarized in Fig. 1. The
outstanding effects of these hormones are an augmentation of the contractile force
of the myocardium, an increase of heart frequence, and an elevation of blood
pressure,-but at the same time a dilation of the coronary arteries. .
Under normal conditions coronary flow is greatly enhanced during O. consump-
tion, but in the case of coronary arteries changed by sclerosis, coronary blood
flow cannot be elevated. In this situation a coronary insufficiency during intake
of nicotine may occur and onset of angina pectoris becomes possible.
These acute effects of nicotine may also play a part in observations in patients
with angina pectoris «'ho showed a decrease in the mean duration of exercise
before the onset of pain after smoking cigarettes with different nicotine content
(5).
In summarizing the evidence presented, we can conclude that nicotine may act
as an additional factor in acute cardiac ischemia and its consequences. Ho%eever,
more evidence is needed, especially with respect to the action of nicotine in
humans.
ACUTE EFFECTS OF CARBON MONOXIDE
Angina pectoris is aggravated by exposure to CO %.hich results in COlib levels
of 3-47e, as has been shown by Aronow (5), and seems to increase the alveolar to
arterial difference in states of chronic hypoxemia (13). Patients with CVD obvi-
ously cannot supply enough oxygen to the myocardium to prevent angina pectoris
in the presence of even low levels of COHb, but this is not valid for healthy- -
people. An oxygen deficiency ih patients with CVD is also suegested by studies of
niLotine
aympcthet¢ nerve gnngba.adrenal medutla,
peripheral nerve endings
r
releose o
htart
pos chronutrop
pas inotrap
coronary perfusion
mueased
cardiac output
increased
rascutarbed
may act;
pOS.chronolrop
pas inotrap
rascutar bed
vcsadilaLOn
muscle 1
rosocanstncLan
( skin7
systolic blood
pressurr elevated
rasocansu,ctmn
eoronary perfusicn
increasrng -
cardicc outputmaybe systolic and dmsto:,c
diastolic bload - decreased ar un - blood pressure elevated
pressure may fcll changed /
automaticity ./
increased
arrythnias may
- appear ___ -
67
Fto. t. Cardiorascular actions of nicotine.

IF04rn-. II. SCIIIISVLLBBIN .
normal blood flow by increasing oxygen extraction. This second option would
subject tissue to lowered oxygen tensions, which does not seem feasible for the
heart. -
Another option revealed by chronically exposed monkeys is a decrease in oxy-
gen consumption. While possible for the systemic circulation, it is probably not
feasible for the myocardium.
A funher attempt at adaptation must be seen in the increase in red blood cell
volume and red blood cell count. Several authors observed polycythemia, eleva-
tion of hematocrit, and in consequence decrease of plasma volume in smokers (2,
37, 44). In contrast to this finding no changes could be observed by us in healthy
volunteer smokers. Our results are in agreement with those of Ayres and co-
workers (9) who found no difference in the hemoglobin concentration-between
smokers and nonsmokers. Maybe this difference in our findings is due to differ-
ent ages of examined persons. -
An elevation of the concentration of 2,3-diphosphoglycer,Lte (2,3-DPG) seems
to be a further compensation mechanism for the influence of CO. This compound
facilitates the delivery of oxygen to the tissues and is a specific metabolic product
of the glycolytic pathway of the erythrocytes. An elevation of this compound was
observed by Astrup (6) in persons at high altitude and by Dinman and co-workers
(18) in humans and rats exposed to CO. This compensation mechanism seems to
work in smokers too. Table 4 indicates some of the results.of our investigations
(41). Healthy male and female volunteers smoked different brands of cigarettes. In
aIL smoking periods, the concentration of 2,3-DPG was elevated in smokers in
contrast to nonsmokers. For further information formation on adaptive changes see Ayres
and co-workers (9).
Finally, as the last option, the opening or the development of collateral blood
vessels must be discussed. -
All of these adaptive responses would probably serve admirably for healthy
men. The development of coronary arteriosclerosis, however, might be predicted
to render any of these adaptive responses ineffective or even dangerous and
expose the myocardium to potentially lethal hypoxia. The results of Aronow and
TABLE 4
CONCENrRATION OF 2.3-DIPHOSPHOOLVCERATE IV RED BLOOD CELLS'
T) pe of ciga.ete
garameter _ E F - B C
K:15 K:14 K19 K:9
N:0.8- N:0.7 N:1 _' N:0.4
CO 4.4 C03 i CO-.3.6 .
COHb (%) 4.2 ~ 1.47° 5.26 x 1.49 4-47 _ 1.73 5.56 _ 2.11
- 3.72±0.64 273-0.5'_ 2.51-0.56
2,3-DPG (mmoVliter 4.16 i 0 70 4.29 i 0.53 4.14 e 0-73 4.24 x 0.68
erythrocytcs) 3.32 c 0.40 3.87 x 0 49 9 3.94 - 0.4'- 3.69 a 0.34
Condensate tK) and nlcotine IN): mg cigareHe: CO: volume ~r.
. r Upper Gne, smokers; lowerline, nonsmokers..C ± S.
opya9hr
:k

rnsVCSTtvE MEDICINE 8, D00-1%]0 (1979)
Evaluation of the Role of Carbon b"lonoxl-Se an
Nicotine in the Pathogenesis of Arteriosclerosis and
Cardiovascular Disease'
H.SCHIEVELBEIN"-
fns(imre of Clinical Chemitln., German Henrt Center, }frmi<h, West GrrnmmThe evidence for the role
of smoking, carbon monoxide (CO1, and nicotine in the etiology of cardiovascular diseases ICVDI is
evaluated critically. Positive statistical correlations
betsceen smoking and CVD obtained in several epidemiological studies demonstrntn the
need to investigate possible causative biological mechanisms. Ambient .^oncentrationc of
CO influence COHb levels in humans. Correlations aro reported between the COHb lecel
and CVD. but we are far from having ciearcut evidence of a public hcalth risk from ambient
CO concentrations. Assuming that a major pan in the etiology of CV D is the development of
arteriosclerosis. investications in this direction have been performed with CO and nicotine fn
animal experiments. Neither substance has any influence, comparable to human ar-
teriosclerosis, on the development of CVD. .
INTRODUCTION
The accompanying papers represent contributions to a conference on the role of
carbon monoxide (CO) on the pathogenesis of cardiovascular diseases (CVD). In spite of this major
subject, the inclusion of nicotine actions seems to be necessary
Wfth regard to the general opinion that nicotine is the most aclive component of
cigarette smoke. -
The extensive epidemiological studies of smoking in relation to health by Doli
and Hill and others, published in the first comprehensive report to the Surgeon -
General (Terry Report) in 1964, that followed the growing realization of the as-
sociation of cigarette smoking With lung cancer delivered statistically convincing
evidence of a similar association with CVD. This association has been confirmed
many times and, particularly impressively, in the Framingham Study by Da«ber,
Kannel and co-workers in 1955 (17). It should be noted that this correlation is
much stronger with cigarette smoking than ailh other forms of tobacco consump-n tion and that it is
strongest in the lower aee group, becoming quite minor in degree
by the age of 65- Furthermore, cigarette smoking is much more strongly related to
the most catastrophic manifestations of ischemic heart disease-sudden death and
myocardial infarction-than to the more or less dramatic manifestations including
angina pectoris.
The problem of the meaning of the association between smoking and CVD is a .
-
difficult one: Is it a direct causative relationship or merely a linked association:' It
_ _ ~
I Presented at a Workshop on Carbon ]tonoxide and Cardiovascular Discase. sponsorcd by the ~
I
American Health Foundauon and the Federal Health Office, Federal Republic of Germany, Berlin.
October 10-C. 1978- .
'To sshom requests for reprims should be addressed: Institute of Clinical Chemistry, Germany '
HeaY, Center Munich. t-othstrasse 11, D-8000 Munich 2-FGR. West Germany.
- 0091-7775179r0083-000t$02 -Q60
.
Cop,M1[bi j 19ri by Academs Re.,. I-
An rilbn of rtpmluclun in any (orm a.errrd.
el- - ~oo.~ - 1
-

WORKSHOP: CARBON MONOXIDE AND CVD
Ayres and co-Workers (10) who demonstrated that CO inhalation causes a shift in
the lactate/pyruvate ratio tossard lactate, meaning a nearly complete conversion of
myocardial metabolism to the glycolytic_pathtvay.
Furthermore, hypoxia of the myocardium due to the diminished delivery of -
oxygen in the presence of COHb may induce cardiac arrhythmia which may be
responsible for sudden-death found more frequently in smokers than in non-
smokers. . _
It is well established that COHb as low as 5% can result in a decrease in
maximal oxygen uptake during exercise in normal young male subjects. It is an
interesting phenomenon that the oxygen uptake is significantly less diminished in
smokers (22). This leads to the question whether adaptive changes may occur in
response to chronic carboxyhemoglobinemia as it is knoun to occur in subjects
living in high altitudes.
These studies and others show a large variability of responses of the organism to
different concentrations of CO. This variability of reactions-to acute and chronic
exposure in studies of men and primates suggest that the mammalian cardiopul-
monary system may exercise one of several options when exposed to car-
boxyhemoglobin hypoxia. _
Increased blood flow could restore tissue oxygen to normal and apparently this
is the solution chosen by the myocardium but not by the systemic circulation. In
Fig. 2, results of Ayres and co-workers (10) in the interpretation of Goldsmith and
Aronow (24) are presented. It can be seen that in fact the myocardium does not
increase oxygen extraction during exercise. -
Another option would be to maintain oxygen consumption without increasing
o Reatiny
syetemi< Coronary
L-L_IJ oxY9en Conrumption / I
2t6xt1 d Evercbe r_l
129 279 L8 10.8
ml/mm ml/min/100 9
Blood Flow
a
I I 1 1 66 90
-3.0 4.7
Umin mUm'n/f009
Ory9en Estrsctlon
from Bbad
I !.3 5.9 118 120
0
mutoo mm minoon+
Fre. 2. The effect of exercise on osygen consumplian, blood flow, ar.d ocygen ealraction from
blood in the systemic and coronary circul;nion in healthy individuals [a0er Ayres and ao-workcrs (
IB)].
Reprinted with permission from Ref. Q4). -
n

, ii , . ., WORKSHOP: CARBON AfONOX1DE AND CVD
knowledge of these facts. only recent investigations have been included in Table
3. The "rnean of the mean" of all nine values for smokers in Table 3 is 6.3Sc
COHb. This should be a realistic value and is far below the concentration which is
expected to cause acute-effects on psychomotor or vigilance performance. (For
investigation of CO yield from cigarettes see Robinson and Forbes, 38-)
In light of the findings by Astrupand co-workers in 1967 in experiments carried
out on rabbits, it was thought that CO in cigarette smoke may have contributed
essentially to the observed effect of smoking upon the alterations of coronary
vessels in men and in animals. Due largely to the study by Astrup and co-workers.
CO has been assigned the role of a major arteriogenic agent in tobacco smoke [for
review see Astrup. (7)1. -
As a result, until 1976 there was little doubt that CO in cigarette smoke is the
principal agent responsible for the development of this disease. in that year
Davies and co-workers (16) presented a study where both coronary artery ar-
teriosclerosis and the-accumulation of cholesterol and lipids in the aorta of rabbits
were measured. In spite of the fact that the experimental design used to test the
hypothesis was that which has been reported to produce the greatest accumulation
of cholesterol in the aortic wall, the obtained-results conflicted with those of
Astrup and co-workers. Davies and co-workers have been unable to confirm that
an exposure to CO results in any significant accumulation of cholesterol in the
aorta of rabbits. But they observed an increase in coronary artery arteriosclerosis
in the animals as measured by the number of internal lesions. In contrast to the
increased number of lesions, the percentage stenosis of affected arteries was
rather higher in the animal group which was not exposed to CO.
Also in 1976, another study was published by Armitage and co-workers (3)
investigating the effects of CO on the development of arteriosclerosis in the white
Carneau pigeon. CO had no enhancing effect in normocholesterolemic birds- In
birds with hypercholesterolemia induced by adding 1% cholesterol to the diet, the
severity of coronary artery arteriosclerosis was significantly higher in birds ex-
posed to CO than in nonexposed birds. But this was only valid after an exposure
time of 52 weeks: it was not detectable after an exposure time of 84 wecks. The
severity of arteriosclerosis was related to the degree of hypercholesterolemia.
In view of these reports demonstrating only negligible effects of CO exposure
on the aortic accumulation of cholesterol, Astrup and co-workers repeated their
previous experimenis. As was shown by Astrup and Kjeldsen (8), a different and
improved assay method showed no influence of CO exposure on the development
of arteriosclerosis in rabbits. _
To summarize the chronic effects of CO on the development of arteriosclerosis
one can say that in numerous experiments, CO had no effect in normocholes-
terolemic animals. Though the epidemiological data suggest an acceptable role for
tobacco smoke in CVD, especially in coronary sclerosis, evidence linking CO as
the causative agent has not been established. Naturally studies in man with single
components of tobacco smoke are not feasible- The statistical corrclation between
CO exposure in tobacco smoke and arteriogenesis may only reflect the fact that
CO and the following COHb levels may be a marker for the intake of other
substances in tobacco smoke.

WORKSHOP: CARBON MONOXIDE AND C\'D
33. lones. 1. G., and Sinclair, A. Arlerial disease amongsl blast furnace rnrlcrs. Amr. lJ, rnp.
ll:e.
18, 15-20t197c1.
34. Kannel. W. B.. McGee. D., and Gcudon, T. A gen<r2l cardiosascvlar risk profile: The Framirgham
studv. Ar,irc J. CnrJinl. 38, 16-51 f1976). .
35. Kullcr. L. H.. Radford. E. P-, Sa ift, D.. Pcrper. J. A., and Fisher. R. Carbon monoxide and
hean
attacks. Arch. Emwnn. fferrlrh 30, 477-48? (1975). - - - - 36. Langone.l. 1.. Gjika. H. B., and van
Vunakis. H. Nicotine and os mctabolijes. Radioimmunoas-
says for nicotine and-colinine. Blnrhrmisln- 12, 50?5-5030 11 9')1.
37.-Okuno, T. Smoking and blood changes. J.41fd 225. 1387-1?88 t I973). '
39. Robinson,J.C..andForbes.F.Theroleofcaibonmonoxideincicueoesmoking.Arrh.Enriron.
Nenlrh 30, 4?5-431 (1975).
39. Scheidemandel, V., and Daum, S. Carboxyhemogiobin concemraiions of the Munich populaiion-
h6irnrhrrr. Sfed. Wnrhrmrhr. 115, 109-11? (1977)-
40. Schievelbein. H.. and Grundke, K. Gas-chromatographische ?iethode zur Oeslimmung von \ico-
tin in Hlut und Gtueben. Z. AnnC. Chrni. 237, 1-8 (l9h8).
41. Schiavelbein. H.. Heinemann, O-, Loeschenkohl. K.. Troll. Clr.. and Schlegel. 1. V<iabolie
aspects of smoking behaviour, in "Smoking Behaviour IR. E. Thurntyn, Ed.l. pp 371-379-
Churchill Livingstont. Edinburgh-Landon-Vew.York, 198-
4_'. Schievclbein. H., Londong. V., Londong. \V., Grumbach, H.. Rreplik. V.. Schauer, A.. and
Immich. H. Nicotire and ateriosclerosis. An expmimental coniribution to the influence of
nicotine on fat metabolism. Z. Klin. Chrm. K(in. Biorhrm. 8. 190-196 ( 1970)-
43. Scott, R. A., Henson. D. E., Lesak, A.. Tumer, R. 1.. Nalikova. S.. and Hass. G. M. Rulaiions
between metabolic increase in plasma free fauy acids and ihc occurrence of arterioscleroiic
thrumhoancritis in.rabbits. Anrrr. J. PrtthnL 70, 209-213(1973).
44. Smith, J. R., and Landa., S. A. Smokers' pol.cy:hcmia..\'. En,l. J. 1/rJ. 298, 6-10119781.
45. Stewart. R- D. Baretla. E. D.. Plaue, L. R., Stewart, E- B.. KalTfkisch. J. H.. van Tserfoo, B.,
and Rimm, A. A. Carboxyhemoclobin levels in American blocd docors.l.l sf.i 229, 1187- 1195
(1974).
46. Turner, D. V., and Topping. D. L. The effect of tobacco smoke and some of its con+timems on
triglyceride secretion in the squirrel munkey. Rex. Canrn:v_n. Clrrm. Pndiol. Pherun:uJ. 12,
85 - 100 (1975).

WORKSHOP: CARBON MONOXIDE AND CVD
co-workers and Anderson and co-workers (I, 5) obtained in patients with CVD
provide some evidence that these conclusion; may be-valid.
With regard to the action of CO, conclusions can be drawn in accordance tcith
the "The Committee on Medical and Biological Effects of Environmental Pollu-
tants, Subcommittee on Carbon lfonoxide of 1977" (14) and in contrast to the
different opinion of AronoW (5) that there is no evidence suegesting a higher
incidence, prevalence, or prognosis of heart disease among industrial lsarkers
who are exposed to high CO concentrations.
Further, it has been shown that nicotine and CO are not components of major
importance for the development of arteriosclerosis and CVD. but in my opinion. on
the basis of damaged coronary_arteries, they may well support the occurrence of
an acute event such as angina pectoris. myocardial infarction, and-sudden death.
With regard to CO the effect may depend on the COHb level in the blood and on
the extent of CVD, but a COHb_level as it is normally found in smokers may not
harm healthy persons.
In my opinion, there is no doubt as to the association of cigarette smoking and
the increased risk for CVD. On the other hand, the interpolation of data from
animal studies With a single smoke component seems to be very hazardous and
may lead to incorrect interpretations, In this connection the experiments of
Turner and Topper (46) should be mentioned. They found that the hepatic lipid
secretion was very different when different amounts of total smoke xvere applied
while maintaining quantitatively similar-CO and nicotine levels.
Finally, it should be borne in mind that we are far from having evaluated all the
causes for CVD. As has been-shown by Kannel and co-uorkers (3-3) the risk
factors investigated in the Framingham Study which are the risk factors known so
far by us, accounted for only one-fifth of the 8-year incidence of coronary heart
disease.
REFERENCES
I. Anderson, E. W., Andelman. R. 1.. Strauch.l. \L. Formin, N. 1., and Knelson. 1. H. Effect of
lowlevel carbon monoxide exposure on onset and duration of angina pecloris. A study in Ien
patients v,ith ischemic heart disease. Ann. Jnrern. Aled. 79, 46-SO t 1973/.
2. Andrus. L. H., Miller, D. C., Stallones. R. A., Ehrlich. S. P-. and Jones. 1. P. Epidemiological
study of coronary disease risk factors. Anrer. J. Epidenrinf. 87, 73-86 f 19581
.
3. Armitage. A. K.. Davies. R. F., and Turner. D. ll. The effects of carbon monoxide on the
development of atherosclerosis in white Carneau pigeon..4rhrrosrleruoii 23, 3'3-334 119761.
4. Armitage. A. K., Dollery, C. T.. George, C. F., Houseman. T. H.- Lewis, P. 1.. and Turner, D.
M. Absorption and metabolism of nicotine by man during cigarette smokieg. Br:r. L Clin.
PGnnnacnl. 1, 18U-181 (1974).
5. Aronow, W. S. Effect of carbon monoxide on eardiocascular diseae. Prer. S/eJ. 8. (%3<7-rXq
(1979).
6. Astrup, P. Intraerythrocytic 2.3-diphosphoglycerate and carbon monoxide exposure..lnn. N.Y.
Acnd. Sci. 174, 252-'-54 (1970).
7. Astrup, P. Studies on carbon mononide and nicotine, in "Smoking and Health. I. Slodif)ing the
Risk for the Smoker " (E. L. wynder. D. HofTmann. and G. B. Gori. Eds.). pp. 371--3J1. U.S.
Department of Hcalth, Education, and Welfare. 1976.
8. Astrup, P., and Kjaldsen, IC Model studies linking carbon monoxide and"or nicotine to ar-
teriosclerosis and cardiovascular diseasa Prn-. )fed. 8, Wr)-000 ( 19791.
9. Ayres, S. M., Evans, R. G., and Beohler, M. L. The prevalence of carboxyhemegJobinemia in
I
i,.l~ ~

.'251o H.SCHIEVEL6EIN - -
New Yorkers and its effects on the coronary and systemic circulation. Prr.t 3fed. 8, 000-000
(1979).
10. Ayres. S. M., Giannelli. S.. Jr., and Mueller, H. Effects of low concentretions of carbon
monoxide. Parl IV..P.tyocardial and systemic responses to carboxyhembglobin Ann. N.Y.
Acad. Sri. 174. ?68-293 ( 1970). -
11. Barnard. R. J., and Duncan. H. W. Heart rate and ECG responscs of frrc 5ghlers.l. Orcup. 31rd.
17, '_47 (1975). - -
12. Bamard. R. J., Gardner, F. W.; Diaco, N. V., and Katlus, A. A- Near-masimal $CG stress testing
and coronary artery disease risk factor analysis in Los Angeles city fire Gghters.J. Ocrup. Afrd.
17, 693-694 (1975). -
13. Brody. J. S.. and Coburn, R. _F. Effects of elevated carboxyhcmoglobin on gas exchange in the
lung. Ann. N. )'. Arnd. Sri. 174, 256-260 (1970). -
14. Carbon monoxide. M1ledical and Biologic Effects of Environmental Pollutants. National Acadcm,v
of Sciences. Washington. D.C.. t977. -
15. Cole. P. V. Comparative effects of atmospheric pollution and cigarette smoking on car-
box)haemcglobin levels in man. Nnturr rLondnn) 255, 699-701 (19751.
16. Davies. R. F., Topping, D. L, and Turner. D. \I. The effect of intermittent carbon monoxide
exposure on experimental atherosclerosis in the rabbil. Arhernsrlerusis 24. 5'-7-536 (1976).
17. Dauber, T. R.. Kannel. W. B.. Revotskic. N.. Slokes, J., Kagan. A., and Gordon, T. Some
factors associated a¢h.the development ofcoronary heart disease. Six }'ears's foilowup experi-
ence in the Framingham Study.Anier, J. PArh. Henlrh ,Vat. Health 49, 1349-1356 (1959).
I8. Dinman. B. D., Eaton, I. W-, and Brewer, G. J. Effects of carbon monoxide on DGP concenrra-
tions in the erythrocyte. Anrr. ;V.Y. Acnd .S6. 174, 246-251 (19701.
19. Do,vle. J. T. Risk factors in arteriosclerosis and cardiovas<ular discasc, with special emphasis
on
cigarette smoking. Prec. M1fed 8, 000-000 (-19791.
20. Fisher. E. R.. Rothstein. R.. Wholey. M. A.. and Nelson. R. Influence of nicoline on
experimental
atherosclerosis and its determinants. Arch.. Pnthril 96, .98 (1973).
21 Garrnson, R. J.. Kannel, W. B., Feinleib, \1. Cutelli, W. P. 61cNamara. P. V., and Padgett. S. 1.
Cigarette smoking and HDL-chofesterol. Arherosderosis 30, 17-'_5 (1978).
22. Gliner. 1. A.. Raven. P. B-, Horvath, S. Af.. Drinkwater. B. L., and Sutton. J. C. Atads
physiologic response lo long-term xork during thermal and pollutanl stress. J. Appl. Phrsiol.
39, 628-632 11975).
23. Goldbourl, U., and lledalie, 1. H. Characteristics of smokers, non-smokers and exsmokers
among 10.000 adult malcs in Israel. Anrer. J. Epidrmiol. 105, 77 11977).
24- Goldsmirh, 1. R., and Aronow, W. S. Carbon monoxide and coronary hean disease: A Review.
Emirun. Rrs. 10, 236-248 (1975). -
25. Goldsmith- 1. R.. and Landaw, S. A. Carbon monoxide and human health. Srirnrr 162,
135'-I359119581.
26. Grosgogeat. Y.. Anguaca, G., Lellouch, 1.. Jacoto. B., and Beaumont. 1.-L. L-intnxication
ehronique par la nicotine chtz le lapin nourri au chnleslero. J. Atherusclrr. Aea- 5, ?91-301
(19651.
27. Hasskins. L- L. Blood carbon monoxide levels as a function of daily cigarette consumption and
phyiical activity. Brit. J. brJ. Aled. 33, 123-129 (1976).
28. Heinemann, G., Loeschenkohl, K., and Schievelbein,.H. Evaluation o_f a suitable method for the
photometric determination cf small amounts ofcarboxyhemoglobin- Xth Intemat. Congress for
Clinical Chemistry, ltexico, February 27-March 3, 1978.
29. Heldxaara, Sf., Karvonen, M. 1., Vilhunen, R., and Punsar. S. Smoking. carbon monoxide, and
atherosclerotic diseases. Brit. ,ifed. J. (, 268-270 (1978)
.
30. Hernberg. S-, Karava, R., Koskela. R.-S., and Luoma, K. Angina pectoris. ECG findings and
blood pressure of foundry workers in relation to carbon monoxide exposure Srand. 1 Wurl,
Emiron. Heulth 2, (Suppl. 1), 54-63 (1976). .
31- Hill. P. Nicotine: An etiological factor for coronary heart disease. in "Smokir.g and Heahh. I.
Modify ing (he Risk for the Smoker" (E. L. Wynder. D. Hoffmann. and G. B. Gori. Eds.). pp.
313-319. U.S. Department of Health, Education. and Welfare. 1976- -
32. Issac, P. F.. and Rand, M. 1. Cigarette smoking and plasma levels of nicotine. .%anrrr iLnndnrq
236, 308 (197'_).
l~
